9 September 2020 · This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
22 February 2022 · Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
22 February 2022 · Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.